IDI, Inc. COGT 深 滬
已收盤 10-17 16:00:00 美东时间
16.39
+0.030
+0.18%
華盛通- 最 高16.50
- 今 開16.14
- 成交量 115.72万股
- 最 低 16.03
- 昨 收 16.36
- 總市值 22.95亿
- 52周最高 16.99
- 市盈率 靜 --
- 換手率 0.83%
- 52周最低 3.72
- 委 比 -89.63%
- 總股本 1.40亿
- 歷史最高 27.80
- 量 比 0.62
- 振 幅 2.87%
- 歷史最低 3.67
- 每 手 1
- 風險率 3.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Needham上调台积电目标价升至360美元！美国银行、摩根士丹利分别获多家机构上调目标价
今日重点评级关注：Rosenblatt：维持HIVE Digital Technologies"买入"评级，目标价从5美元升至10美元；摩根大通：维持Array Technologies"超配"评级，目标价从13美元升至15美元
10-17 09:58
F.N.B. Corporation Reports Third Quarter 2025 Earnings
Earnings per Diluted Common Share of $0.41, a 37% Increase From the Prior Year (21% on an Operating Basis (non-GAAP)), Driven By Record Revenue of $457 Million with Tangible Book Value Per C...
10-17 04:30
Stifel Initiates Coverage On Cogent Biosciences with Hold Rating, Announces Price Target of $16
Stifel analyst Laura Prendergast initiates coverage on Cogent Biosciences (NASDAQ:COGT) with a Hold rating and announces Price Target of $16.
10-16 21:41
Theriva Biologics To Present VCN-12 And VCN-01 Preclinical Data At ESGCT, Highlighting Novel Antitumor Mechanism And Intracranial Feasibility For Brain Tumors
- Preclinical data for VCN-12, the next candidate from Theriva's VCN-X discovery program, highlight a novel mechanism of action with the potential to significantly improve antitumor effects -- Pre-ESGCT meeting monograph
10-06 20:03
Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cogent Biosciences, a biotech company focused on precision therapies for genetically defined diseases, announced that its independent Compensation Committee granted equity awards to 10 new employees under the 2020 Inducement Plan. The awards, totaling 299,200 nonqualified stock options, were approved on September 25, 2025, with a grant date of September 29, 2025, and a four-year vesting schedule. The company also highlighted its advanced clinical...
09-29 20:05
MPS Completes Major IDITSuite Upgrade with Sapiens
Medical Protection Society has upgraded to a new version of IDITSuite for Property & Casualty, gaining future-proof architecture and extended lifecycle support ROCHELLE PARK, N.J., Sept. 17,...
09-17 19:11
Cogent Biosciences Signs Lease for New Headquarters
An update from Cogent Biosciences ( ($COGT) ) is now available. On September 5,...
09-12 05:04
美股大行评级 | 潜在涨幅403.28%！瑞杰金融首予Kalaris Therapeutics"强烈买入"评级，目标价23美元
今日重点评级关注：花旗：维持Ionis Pharmaceuticals"买入"评级，目标价从69美元升至84美元；Melius Research：上调康明斯评级至"买入"，目标价500美元
09-04 09:49
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones index falling over 150 points on Wed...
09-03 22:10
Guggenheim Maintains Buy on Cogent Biosciences, Raises Price Target to $20
Guggenheim analyst Charles Zhou maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price target from $17 to $20.
08-25 20:21
